The Manufacturers Life Insurance Company reduced its stake in Palomar Holdings, Inc. (NASDAQ:PLMR – Free Report) by 12.8% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 64,132 shares of the company’s stock after selling 9,431 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Palomar were worth $7,664,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in Palomar by 2.5% during the fourth quarter. Vanguard Group Inc. now owns 2,698,278 shares of the company’s stock valued at $363,620,000 after purchasing an additional 67,038 shares during the period. Westfield Capital Management Co. LP increased its position in Palomar by 13.8% in the fourth quarter. Westfield Capital Management Co. LP now owns 840,226 shares of the company’s stock worth $113,229,000 after buying an additional 101,698 shares in the last quarter. Janus Henderson Group PLC raised its stake in shares of Palomar by 250.1% in the fourth quarter. Janus Henderson Group PLC now owns 795,625 shares of the company’s stock worth $107,237,000 after buying an additional 568,360 shares during the period. Sumitomo Mitsui Trust Group Inc. lifted its position in shares of Palomar by 72.1% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 785,165 shares of the company’s stock valued at $105,809,000 after buying an additional 328,993 shares in the last quarter. Finally, Stephens Investment Management Group LLC lifted its holdings in Palomar by 3.0% during the first quarter. Stephens Investment Management Group LLC now owns 714,914 shares of the company’s stock valued at $85,432,000 after purchasing an additional 20,597 shares in the last quarter. 90.25% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
PLMR has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. upped their price target on shares of Palomar from $150.00 to $167.00 and gave the stock an “overweight” rating in a research report on Monday, July 20th. Evercore set a $152.00 price target on Palomar in a report on Friday, July 10th. Piper Sandler boosted their price objective on Palomar from $132.00 to $165.00 and gave the company an “overweight” rating in a research report on Wednesday, July 15th. Keefe, Bruyette & Woods upped their price target on Palomar from $162.00 to $166.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 8th. Finally, Zacks Research lowered shares of Palomar from a “strong-buy” rating to a “hold” rating in a report on Friday, May 15th. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $162.50.
More Palomar News
Here are the key news stories impacting Palomar this week:
- Positive Sentiment: Palomar reported second-quarter EPS of $2.36, exceeding analysts’ $2.19 consensus estimate by $0.17 and rising from $1.76 in the prior-year quarter. The company also posted a 22.62% return on equity and a 20.11% net margin. Palomar Holdings, Inc. Reports Second Quarter 2026 Results
- Neutral Sentiment: COO Rodolphe Herve sold 1,207 shares worth approximately $163,367. The filing said the transaction was intended to cover tax-withholding obligations tied to vested equity awards, making it less indicative of a bearish view on the company. Palomar insider transaction
- Negative Sentiment: Revenue was reported at $314.42 million, well below the approximately $621.5 million analyst expectation cited in the earnings coverage. Even with the EPS beat, the reported top-line miss could raise concerns about growth and operating performance. Palomar Q2 Earnings Snapshot
- Negative Sentiment: Zacks Research lowered its fiscal 2028 EPS estimate to $10.45 from $10.62 and maintained a “Hold” rating. The revision signals somewhat weaker longer-term earnings expectations, although the current-year consensus remains $8.90 per share. Palomar analyst estimate revision
Insider Activity
In other Palomar news, COO Rodolphe Herve sold 1,207 shares of the company’s stock in a transaction on Friday, July 31st. The stock was sold at an average price of $135.35, for a total value of $163,367.45. Following the transaction, the chief operating officer owned 3,548 shares of the company’s stock, valued at $480,221.80. This represents a 25.38% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Mac Armstrong sold 3,500 shares of the stock in a transaction on Tuesday, July 21st. The stock was sold at an average price of $137.26, for a total value of $480,410.00. Following the completion of the sale, the chief executive officer owned 325,888 shares in the company, valued at approximately $44,731,386.88. The trade was a 1.06% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 22,050 shares of company stock valued at $2,875,050. Company insiders own 3.70% of the company’s stock.
Palomar Price Performance
Palomar stock opened at $136.11 on Wednesday. The company has a quick ratio of 0.49, a current ratio of 0.49 and a debt-to-equity ratio of 0.31. Palomar Holdings, Inc. has a 52-week low of $100.81 and a 52-week high of $147.62. The firm’s fifty day moving average is $125.19 and its 200 day moving average is $123.58. The company has a market cap of $3.61 billion, a price-to-earnings ratio of 18.96 and a beta of 0.40.
Palomar (NASDAQ:PLMR – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $2.36 EPS for the quarter, topping the consensus estimate of $2.19 by $0.17. Palomar had a return on equity of 22.62% and a net margin of 20.11%.The company had revenue of $314.42 million during the quarter, compared to analyst estimates of $621.52 million. During the same quarter last year, the business posted $1.76 earnings per share. Sell-side analysts forecast that Palomar Holdings, Inc. will post 8.9 EPS for the current fiscal year.
Palomar Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 2nd. Investors of record on Wednesday, August 19th will be issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 1.3%. The ex-dividend date is Wednesday, August 19th.
Palomar Company Profile
Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.
Read More
- Five stocks we like better than Palomar
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Want to see what other hedge funds are holding PLMR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Palomar Holdings, Inc. (NASDAQ:PLMR – Free Report).
Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.
